Cosciens Biopharma Inc logo

Cosciens Biopharma Inc

NEW
NAS:CSCI (Canada)  
$ 3.46 +0.050 (+1.47%) 11:41 AM EST
At Loss
P/B:
1.01
Market Cap:
$ 11.04M
Enterprise V:
$ -648.00K
Volume:
517.00
Avg Vol (2M):
2.93K
Trade In:
Volume:
517.00
At Loss
Avg Vol (2M):
2.93K

Cosciens Biopharma Inc’s share price is $3.46. Its GF Value is $5.64. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Cosciens Biopharma Inc stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: $3.46 GF Value Price/GF Value
Current $5.64 0.61
Next FY1 End $5.13 0.67
Next 12 Month $4.62 0.75
Next FY2 End $4.25 0.81
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Cosciens Biopharma Inc's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Cosciens Biopharma Inc's stock price and Operating Cash Flow per share, with a coefficient of 95%. This is followed by a 93% correlation with Earnings without NRI per share and a 89% correlation with Book Value per share. The weakest correlation is observed with Book Value per share, at 72%.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies